The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
In an extraordinary 6,000-word guest editorial in the October 2024 issue of The CRISPR Journal (a sister journal of GEN, published by Mary Ann Liebert, Inc.), Fyodor Urnov, PhD, laid out the urgent ...